Biocon Biologics’ Denosumab biosimilars, Vevzuo and Evfraxy, have received marke...
Brii Biosciences and Joincare Pharmaceutical have signed a licence and technolog...
Merck KGaA has concluded the previously announced acquisition of SpringWorks The...
By 2030, the cell and gene therapy market is projected to be worth £76.03bn, and...
Life science professionals must navigate a complex regulatory maze to implement ...
A new podcast from industry experts MarketScan explains why social determinants ...
Dizal has received FDA approval for Zegfrovy to treat adults with locally advanc...
The UK Government is pushing for a single, unified digital patient record within...
Analysis shows Gilead’s recently approved drug for HIV prevention, Yeztugo, has ...
Sanofi is to invest up to $25m in Adagene, which will enable the latter to fund ...
US President Donald Trump’s One Big Beautiful Bill Act (H.R. 1) has narrowly pas...
With its blockbuster Trikafta set to lose patent protection within the decade, V...
The FDA has approved Sobi's Gamifant (emapalumab) to treat adults and children w...
Torrent has signed definitive agreements to acquire stake in JB Pharma at an equ...
As the pharma sector braces for sector-specific tariffs from President Trump, wh...
Vetter Pharma, has begun the construction of a new clinical manufacturing facili...
